Olle Larsson

11.0k citations

212 papers · 8.5k indexed · h-index 51

Impact in

Endocrinology, Diabetes and Metabolism top 0.5%
- Growth Hormone and Insulin-like Growth Factors
Oncology top 1%
- Cancer-related Molecular Pathways

Papers in

Cancer Research 35
- Cancer, Hypoxia, and Metabolism 15
Oncology 56
- Cancer-related Molecular Pathways 12

Co-authors: Leonard Girnita Ada Girnita Anders Zetterberg Magnus Axelson Armando Bartolazzi Bita Sehat Stefan Seregard Johan Wejde
Journals: Oncogene (9 papers)Journal of Cellular Physiology (8 papers)Clinical Cancer Research (7 papers)Journal of Cell Science (7 papers)Journal of Biological Chemistry (6 papers)
Partner nations: Sweden United States Belgium

In The Last Decade

Olle Larsson

210 papers receiving 8.3k citations

Peers

Countries citing papers authored by Olle Larsson

Since Specialization

Citations

This map shows the geographic impact of Olle Larsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olle Larsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olle Larsson more than expected).

Fields of papers citing papers by Olle Larsson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olle Larsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olle Larsson. The network helps show where Olle Larsson may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Olle Larsson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Olle Larsson Line = papers co-authored together Olle Larsson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Comprehensive Genomic Profiling Alters Clinical Diagnoses in a Significant Fraction of Tumors Suspicious of Sarcoma Clinical Cancer Research ·Ingegerd Öfverholm, Jesus Rey, Андреева Кюннэй Егоровна, Guokui Tian, Johan Wejde, Бойко Анна Степановна, Valtteri Wirta, Duivenvoorden Hj, Eva Caceres, C.H.M. Smits, Markus Mayrhofer, Andri Papakonstantinou, A.A. Glelah, Robert Bränström, Olle Larsson, Johan Lindberg, Yingbo Lin, Felix Haglund	2024	4
2	Interdependence of SS18-SSX–driven YAP1 and β-Catenin Activation in Synovial Sarcoma Molecular Cancer Research ·LI Huanfang, Young Woong Kang, G N Lenko, Eva Wardelmann, Olle Larsson, Marcel Trautmann, Wolfgang Hartmann	2023	3
3	Editorial Expression of Concern: Gene expression profile by blocking the SYT-SSX fusion gene in synovial sarcoma cells. Identification of XRCC4 as a putative SYT-SSX target gene Oncogene ·Yuntao Xie, Islamic Home Entertaiment, Yan Aalto, Gunnar Nilsson, Leonard Girnita, Bálint Nagy, Sakari Knuutila, Olle Larsson	2022	0
4	TERT promoter mutation is an objective clinical marker for disease progression in chondrosarcoma Modern Pathology ·Yifan Zhang, Yi Chen, Yang Chen, In German, Asle C. Hesla, C.H.M. Smits, Olle Larsson, Yingbo Lin, Felix Haglund	2021	25
5	Nuclear IGF1R interact with PCNA to preserve DNA replication after DNA-damage in a variety of human cancers PLoS ONE ·Yang Chen, Yifan Zhang, Yi Chen, Нора Теш, Mingzhi Liu, Sara Corvigno, Hanna Dahlstrand, Joseph W. Carlson, Zihua Chen, Anders Näsman, Vassilios Karavelidis, Yingbo Lin, Olle Larsson, Felix Haglund	2020	12
6	SS18-SSX–Dependent YAP/TAZ Signaling in Synovial Sarcoma Clinical Cancer Research ·LI Huanfang, Dhanvanth Singari, Yo Han Song, Sareetha Kailayangiri, Bianca Altvater, Claudia Rössig, Konrad Steinestel, Inga Grünewald, Sebastian Huss, Eva Eßeling, Jan‐Henrik Mikesch, Susanne Häfner, Thomas Simmet, Agnieszka Woźniak, Patrick Schöffski, Olle Larsson, Eva Wardelmann, Marcel Trautmann, Wolfgang Hartmann	2019	38
7	SUMO‐modified insulin‐like growth factor 1 receptor (IGF‐1R) increases cell cycle progression and cell proliferation Journal of Cellular Physiology ·Yingbo Lin, Hongyu Liu, Vassilios Karavelidis, Felix Haglund, Prasoon Agarwal, Helena Jernberg‐Wiklund, Ou Zhuo Lang, Olle Larsson	2017	36
8	Microenvironmental Targets in Sarcoma Frontiers in Oncology ·Monika Ehnman, Olle Larsson	2015	22
9	Recurrent PRDM10 Gene Fusions in Undifferentiated Pleomorphic Sarcoma Clinical Cancer Research ·Jakob Hofvander, Johnbosco Tayebwa, Jenny Nilsson, Linda Magnusson, Otte Brosjö, Olle Larsson, Fredrik Vult von Steyern, Nils Mandahl, Christopher D.�M. Fletcher, Fredrik Mertens	2014	53
10	Local Control of Nuclear Calcium Signaling in Cardiac Myocytes by Perinuclear Microdomains of Sarcolemmal Insulin-Like Growth Factor 1 Receptors Circulation Research ·Cristián Ibarra, José M. Vicencio, Manuel Estrada, Yingbo Lin, Paola Di Rocco, 俊弘阿部, Juan Pablo Muñoz, Jaime García‐Prieto, Andrew F. G. Quest, Mario Chiong, Sean M. Davidson, Venkata Dinesh Reddy Palagiri, Karl‐Henrik Grinnemo, Olle Larsson, György Szabadkai, Per Uhlén, Enrique Jaimovich, Sergio Lavandero	2012	67
11	The HDAC Inhibitor LBH589 Enhances the Antimyeloma Effects of the IGF-1RTK Inhibitor Picropodophyllin Clinical Cancer Research ·Miguel Lemaire, Siehe Okamoto, Prasoon Agarwal, Eline Menu, Els Van Valckenborgh, Elke De Bruyne, Anders Österborg, Peter Atadja, Olle Larsson, Magnus Axelson, Ben Van Camp, Helena Jernberg‐Wiklund, Karin Vanderkerken	2012	13
12	The insulin‐like growth factor‐I receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells Acta Ophthalmologica ·Ada Girnita, Charlotta All‐Ericsson, Mario A. Economou, J.C. Olivry, Magnus Axelson, Stefan Seregard, Olle Larsson, Leonard Girnita	2008	18
13	A Novel Case of Synovial Sarcoma of the Kidney: Impact of SS18/SSX Analysis of Renal Hemangiopericytoma-like Tumors Diagnostic Molecular Pathology ·Claudia Arellano Vázquez, Johan Wejde, Seema Fotedar, Bertha Brodin, Olle Larsson	2004	25
14	The SYT-SSX1 fusion type of synovial sarcoma is associated with increased expression of cyclin A and D1. A link between t(X;18)(p11.2; q11.2) and the cell cycle machinery Oncogene ·Yuntao Xie, Björn Skytting, Gunnar Nilsson, R. J. Grimer, M Bannazadeh Mahani, Cyril Fisher, Janet Shipley, Bodil Bjerkehagen, Ola Myklebost, Olle Larsson	2002	36
15	Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions The Lancet ·Armando Bartolazzi, Alessandra Gasbarri, Mauro Papotti, G Bussolati, Prof.Dr.Ir. Oemi Hani'in Suseno, Ashraf Khan, Hidenori Inohara, Ferdinando Marandino, Fabio Orlandi, Francesco Nardi, Andrea Vecchione, Raffaele Tecce, Olle Larsson	2001	316
16	Clinical Importance of Genomic Imbalances in Synovial Sarcoma Evaluated by Comparative Genomic Hybridization Cancer Genetics and Cytogenetics ·Björn Skytting, Daphna E Dor‐Shiffer, Yan Aalto, Tamara Lushnikova, Carl Blomqvist, Inkeri Elomaa, Olle Larsson, Sakari Knuutila	1999	33
17	Mevalonate-regulated mechanisms in cell growth control: role of dolichyl phosphate in expression of the insulin-like growth factor-1 receptor (IGF-1R) in comparison to Ras prenylation and expression of c-myc Glycobiology ·Anica Dricu, Min Wang, Magnus Hjertman, CEROID, Harald Blegen, Johan Wejde, Magdalena Carlberg, Olle Larsson	1997	52
18	Evidence for protein dolichylation FEBS Letters ·Magnus Hjertman, Johan Wejde, Anica Dricu, Magdalena Carlberg, William J. Griffiths, Jan Sjövall, Olle Larsson	1997	27
19	Mevalonate Is Essential for Growth Activation of Human Fibroblasts: Evidence for a Critical Role of Protein Glycosylation in the Prereplicative Period Experimental Cell Research ·Magdalena Carlberg, Magnus Hjertman, Johan Wejde, Olle Larsson	1994	12
20	Neuropeptide y- and alpha-adrenergic receptors in pig spleen: Localization, binding characteristics, cyclic amp effects and functional responses in control and denervated animals Neuroscience ·Jan M. Lundberg, Anette Hemsén, A. Rudehill, Anders Härfstrand, Olle Larsson, Alf Sollevi, Alois Saria, Tomas Hökfelt, Kjell Fuxé, Bertil B. Fredholm	1988	59

About Olle Larsson

Olle Larsson is a scholar working on Cancer Research, Oncology, Endocrinology, Diabetes and Metabolism, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 212 papers that have together received 8.5k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (50 papers), Growth Hormone and Insulin-like Growth Factors (28 papers), Plant biochemistry and biosynthesis (23 papers), Ubiquitin and proteasome pathways (22 papers), Cancer, Hypoxia, and Metabolism (15 papers), Cardiac tumors and thrombi (14 papers), Glycosylation and Glycoproteins Research (14 papers) and Cancer-related Molecular Pathways (12 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.6k citations), Oncology (2.5k citations), Cancer Research (1.3k citations), Pulmonary and Respiratory Medicine (2.2k citations) and Ophthalmology (600 citations). Olle Larsson has collaborated with scholars based in Sweden, United States and Belgium. Frequent co-authors include Leonard Girnita, Ada Girnita, Anders Zetterberg, Magnus Axelson, Armando Bartolazzi, Bita Sehat, Stefan Seregard, Johan Wejde, Klas G. Wiman and Björn Skytting. Their work appears in journals such as Oncogene, Journal of Cellular Physiology, Clinical Cancer Research, Journal of Cell Science and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact